is this another ventracor

Is this going to be another australian biotech that seems to have a pretty good product but yet just does not attract any investor support and gradually the share price just dwindles down.

No support for this stock and I can see it going back down to 60 cents again. Dont get me wrong I am a believer in the technology but it is certainly frustrating to be a holder. If the share price does not pick up before the major shareholders holdings come out of escrow we could see them take some pretty good tax losses and force this down real low. They raised capital at $1.50 last time. WHen those shares come out of escrow they could get dumped big time..